Management of community-acquired pneumonia in a university hospital: Adherence to recommended practice guidelines

Santo Tomas Journal of Medicine

Volumn 53, Issue 2, 2006, Pages 37-44

  Tan, Catherine C ^a   Ong Mateo, Marilyn ^a  

^a UNIVERSITY OF SANTO TOMAS HOSPITAL   (Philippines)

Author keywords

Community acquired pneumonia; Guideline adherence; Retrospective study

Indexed keywords

AMPICILLIN; ANTIBIOTIC AGENT; AZITHROMYCIN; BETA LACTAM ANTIBIOTIC; CARBAPENEM; CEFEPIME; CEFTRIAXONE; CEFUROXIME; CEPHALOSPORIN DERIVATIVE; CHLORAMPHENICOL; CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; GENTAMICIN; IMIPENEM; MACROLIDE; OXACILLIN; PENICILLIN G; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULTAMICILLIN; TETRACYCLINE; VANCOMYCIN;

ADULT; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM CULTURE; BLOOD CULTURE; COMMUNITY ACQUIRED PNEUMONIA; COMORBIDITY; CONTROLLED STUDY; DATA ANALYSIS; DISEASE SEVERITY; DRUG SUBSTITUTION; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; FEMALE; HOSPITAL ADMISSION; HUMAN; INFECTION PREVENTION; INTENSIVE CARE UNIT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MEDICAL CARE; MEDICAL PRACTICE; MEDICAL RECORD REVIEW; MONOTHERAPY; MORTALITY; NONHUMAN; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PHILIPPINES; PHYSICIAN ATTITUDE; PRACTICE GUIDELINE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SPUTUM CULTURE; THORAX RADIOGRAPHY; UNIVERSITY HOSPITAL;

EID: 33750061356     PISSN: 03713520     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Barlow GD, Lamping DL, Davey PG, Nathwani D. Evaluation of outcomes in community-acquired pneumonia: a guide for patients, physicians, and policymakers. Lancet 2003;3:476-88.
2. Philippine Health Statistics, 1998 and 2001. Health Intelligence Service, Department of Health, Republic of the Philippines.
3. Magalit PN, Sorongon EMD, Tupasi TE. Antibiotic usage in community-acquired pneumonia in a tertiary care hospital. Phil J Microbial Infect Dis 1997;26:109-12.
4. Fine MJ, Auble TE, Yealy DM, Hanusa BH, Weissfeld LA, Singer DE, et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 1997;336:243-50.
5. Panaligan MM, Alcantara MMF, Pena AC. Management of community-acquired pneumonia among in-patients in a teaching institution: adherence to the American Thoracic Society Guidelines. Phil J Microbiol Infect Dis 1998;27:55-61.
6. Carandang RA, Mendoza MT. A clinical practice guideline-directed surveillance study of admitted patients with community acquired pneumonia. Phil J Internal Medicine 2002;40:193-9.
7. Gould IM. A review of the role of antibiotic policies in the control of antibiotic resistance. J Antimicrob Chemother 1999;43:459-65.
8. American Thoracic Society. Guidelines for the management of adults with community-acquired pneumonia: diagnosis, assessment of severity, antimicrobial therapy, and prevention. Am J Respir Crit Care Med 2001:163:1730-2001.
9. Bartlett JG, Breiman RF, Mandell LA, File TM. Community-acquired pneumonia in adults: guidelines for management. The Infectious Diseases Society of America. Clin Infect Dis 1998;26:811-38.
10. The Philippine clinical practice guidelines on the diagnosis, empiric management of community-acquired pneumonia in immunocompetent adults: a quick reference guide for clinicians. Phil J Microbiol Infect Dis 2002;31:74-84.
11. Villa ML, Sumagaysay I, We M, Co V, Mendoza MT, Tupasi TE, et al. Current clinical practice in the management of community-acquired pneumonia: an appraisal. Phil J Microbiol Infect Dis 1999: 28:121-7.
12. Panaligan MM, Magtolis LG, Pena AC. Influence of blood culture and sensitivity results in the antibiotic choices of attending physicians in the management of bacteremia. Phil J Microbial Infect Dis 1998;27:28-32.
13. Cabana MD, Rand CS, Powe NR, Wu AW, Wilson MH, Abboud PA, et al. Why don't physicians follow clinical practice guidelines? A framework for improvement. JAMA 1999;282:1458-65.